SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (5156)8/14/1998 10:11:00 AM
From: Joe E.  Read Replies (1) of 6136
 
Life Sciences for DuPont goes beyond biotech and includes plant sciences, somewhat widening the possibilities. Still, Agouron would be a cozy fit.
On another subject, If the oncology division were distributed now at 4 for 1, it would get a price of $10 or so , based upon my earlier postings. This would knock Agouron pharma division down by about $2.50.
I make this oncology forecast solely to look stupid later.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News